• Fiscal Year end for Brainstorm Cell Therapeutics Inc falls in the month of December .

    All items in Millions except EPS data.

    12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
    Sales 0 0 0 0 0
    Cost Of Goods 0 0 0 0 0
    Gross Profit 0 0 0 0 0
    Selling & Adminstrative & Depr. & Amort Expenses 21 25 25 32 23
    Income After Depreciation & Amortization -21 -25 -25 -32 -23
    Non-Operating Income 4 1 0 0 0
    Interest Expense 0 0 0 0 0
    Pretax Income -17 -24 -24 -32 -23
    Income Taxes 0 0 0 0 0
    Minority Interest 0 0 0 0 0
    Investment Gains/Losses 0 0 0 0 0
    Other Income/Charges 0 0 0 0 0
    Income From Cont. Operations -17 -24 -24 -32 -23
    Extras & Discontinued Operations 0 0 0 0 0
    Net Income (GAAP) -17 -24 -24 -32 -23
    Depreciation Footnote 12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
    Income Before Depreciation & Amortization -21 -25 -24 -31 -23
    Depreciation & Amortization (Cash Flow) 0 0 0 0 0
    Income After Depreciation & Amortization -21 -25 -25 -32 -23
    Earnings Per Share Data 12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
    Average Shares 2.87 2.44 2.41 1.99 1.46
    Diluted EPS Before Non-Recurring Items -7.65 -9.90 -10.20 -16.04 -15.89
    Diluted Net EPS (GAAP) -6.00 -9.90 -10.19 -16.04 -15.89

    Fiscal Year end for Brainstorm Cell Therapeutics Inc falls in the month of December .

    All items in Millions except EPS data.

    9/30/24 6/30/24 3/31/24 12/31/23 9/30/23
    Sales 0.00 0.00 0.00 0.00 0.00
    Cost Of Goods 0.00 0.00 0.00 0.00 0.00
    Gross Profit 0.00 0.00 0.00 0.00 0.00
    SG&A, R&D, and Dept/Amort Expenses 3.05 2.98 2.47 4.81 6.04
    Income After SG&A, R&D, and Dept/Amort Expenses -3.05 -2.98 -2.47 -4.81 -6.04
    Non-Operating Income 0.34 0.44 -0.93 -0.77 4.81
    Interest Expense 0.00 0.00 0.00 0.00 0.00
    Pretax Income -2.71 -2.54 -3.40 -5.58 -1.23
    Income Taxes 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Investment Gains/Losses 0.00 0.00 0.00 0.00 0.00
    Other Income/Charges 0.00 0.00 0.00 0.00 0.00
    Income From Cont. Operations -2.71 -2.54 -3.40 -5.58 -1.23
    Extras & Discontinued Operations 0.00 0.00 0.00 0.00 0.00
    Income (GAAP) -2.71 -2.54 -3.40 -5.58 -1.23
    Earnings Per Share Data 9/30/24 6/30/24 3/31/24 12/31/23 9/30/23
    Average Shares 4.79 4.82 4.32 2.87 2.95
    Diluted EPS Before Non-Recurring Items -1.80 -0.60 -0.75 -1.65 -2.10
    Diluted Net EPS (GAAP) -0.51 -0.60 -0.75 -1.50 -0.45